AB0827 IMPACT OF BASELINE BODY MASS INDEX ON THE EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-eular.993
Abstract: Background: Obesity is highly prevalent in PsA (~45%)1 and is associated with a reduced response to TNF inhibitors.2 Tofacitinib is an oral Janus kinase inhibitor for the treatment of PsA. Objectives: This post hoc analysis… read more here.
Keywords: inc employee; pfizer inc; pfizer; shareholder pfizer ... See more keywords